These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 33048349)

  • 21. Hidradenitis Suppurativa as a Potential Subtype of Autoinflammatory Keratinization Disease.
    Nomura T
    Front Immunol; 2020; 11():847. PubMed ID: 32508815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.
    Del Duca E; Morelli P; Bennardo L; Di Raimondo C; Nisticò SP
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment options in severe hidradenitis suppurativa].
    Mooij JE; van't Oost L; Leenarts MF; Mekkes JR
    Ned Tijdschr Geneeskd; 2011; 155():A1912. PubMed ID: 21426594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Hidradenitis Suppurativa With T Helper 1/T Helper 17 Phenotypes: A Semantic Map Analysis.
    Thomi R; Cazzaniga S; Seyed Jafari SM; Schlapbach C; Hunger RE
    JAMA Dermatol; 2018 May; 154(5):592-595. PubMed ID: 29617527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa.
    Molinelli E; Gioacchini H; Sapigni C; Diotallevi F; Brisigotti V; Rizzetto G; Offidani A; Simonetti O
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipidomics Profiling of Hidradenitis Suppurativa Skin Lesions Reveals Lipoxygenase Pathway Dysregulation and Accumulation of Proinflammatory Leukotriene B4.
    Penno CA; Jäger P; Laguerre C; Hasler F; Hofmann A; Gass SK; Wettstein-Ling B; Schaefer DJ; Avrameas A; Raulf F; Wieczorek G; Lehmann JCU; Loesche C; Roth L; Röhn TA
    J Invest Dermatol; 2020 Dec; 140(12):2421-2432.e10. PubMed ID: 32387270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26.
    Scala E; Di Caprio R; Cacciapuoti S; Caiazzo G; Fusco A; Tortorella E; Fabbrocini G; Balato A
    Br J Dermatol; 2019 Nov; 181(5):1038-1045. PubMed ID: 30829398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support.
    Danby FW; Jemec GB; Marsch WCh; von Laffert M
    Br J Dermatol; 2013 May; 168(5):1034-9. PubMed ID: 23320858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa/ acne inversa.
    Frew JW; Navrazhina K; Marohn M; Lu PC; Krueger JG
    Exp Dermatol; 2019 Aug; 28(8):886-891. PubMed ID: 31140657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.
    Campione E; Lanna C; Diluvio L; Cannizzaro MV; Grelli S; Galluzzo M; Talamonti M; Annicchiarico-Petruzzelli M; Mancini M; Melino G; Candi E; Schiavone G; Wang Y; Shi Y; Bianchi L
    Cell Cycle; 2020 Feb; 19(3):257-267. PubMed ID: 31905036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-Time Confocal Imaging for Hidradenitis Suppurativa: Description of Morphological Aspects and Focus on the Role of Follicular Ostia.
    Cappilli S; Giovanardi G; Di Stefani A; Longo C; Perino F; Chiricozzi A; Peris K
    Dermatology; 2021; 237(5):705-711. PubMed ID: 33588411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiology of hidradenitis suppurativa.
    Hoffman LK; Ghias MH; Lowes MA
    Semin Cutan Med Surg; 2017 Jun; 36(2):47-54. PubMed ID: 28538743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment.
    Napolitano M; Megna M; Timoshchuk EA; Patruno C; Balato N; Fabbrocini G; Monfrecola G
    Clin Cosmet Investig Dermatol; 2017; 10():105-115. PubMed ID: 28458570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update on the pathogenesis of hidradenitis suppurativa: implications for therapy.
    Negus D; Ahn C; Huang W
    Expert Rev Clin Immunol; 2018 Apr; 14(4):275-283. PubMed ID: 29509041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hidradenitis suppurativa: an update.
    Ingram JR
    Clin Med (Lond); 2016 Feb; 16(1):70-3. PubMed ID: 26833521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting Metabolic Syndrome in Hidradenitis Suppurativa by Phytochemicals as a Potential Complementary Therapeutic Strategy.
    Witte K; Wolk K; Witte-Händel E; Krause T; Kokolakis G; Sabat R
    Nutrients; 2023 Aug; 15(17):. PubMed ID: 37686829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel Disease.
    Lukach AJ; Saul MI; Ferris LK; Swoger JM
    Dig Dis Sci; 2018 Mar; 63(3):755-760. PubMed ID: 29357084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Boils at Frictional Locations in a Patient with Hidradenitis Suppurativa.
    Boer J; Mihajlovic D
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):303-304. PubMed ID: 28128084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β.
    van der Zee HH; de Ruiter L; van den Broecke DG; Dik WA; Laman JD; Prens EP
    Br J Dermatol; 2011 Jun; 164(6):1292-8. PubMed ID: 21332464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hidradenitis suppurativa: a review of cause and treatment.
    Yazdanyar S; Jemec GB
    Curr Opin Infect Dis; 2011 Apr; 24(2):118-23. PubMed ID: 21192260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.